PSYC FPX 4310 assessment 1

Introduction

The underlying theme of this evaluation is about the Neurobiology of Ecstasy (MDMA) abuse in examining various attitudes towards biological psychology through a peer-reviewed article critique.

MDMA, or 3,4-methylenedioxymethamphetamine, is a psychotropic compound that is normally consumed recreationally due to its euphoric and social impact (Montgomery & Roberts, 2022). Nevertheless, its intricate pharmacology profile has spurred research into therapeutic applications such as the management of Post-Traumatic Stress Disorder (PTSD) and anxiety.

MDMA primarily acts on the serotonin system within the brain, preventing reuptake of serotonin and leading to heightened serotonin signaling, thus creating a sense of good effects and feelings of warmth associated with the drug.

The misuse of MDMA is reported to have adverse short and long-term effects, such as physical and mental health problems like dehydration, hyperthermia, anxiety, depression, and alterations in brain structure and function. Knowledge of the neurobiology of MDMA misuse is required for the development and implementation of effective prevention and treatment strategies, guiding public health policy, and averting the harms resulting from its misuse.

Search Strategies

To get information about the neurobiology of MDMA abuse, various search terms were used, some of which were “MDMA,” “ecstasy,” “3,4-methylenedioxymethamphetamine,” “neurobiology,” “abuse,” “brain,” “neurotransmitter,” “serotonin,” “dopamine,” “noradrenaline,” “reward,” “arousal,” “dependence,” “toxicity,” “cognitive effects,” “mental health,” “prevention,” and “treatment.”

Specific methods were applied in the research, including searches in the Capella University Library using Boolean operators and related words. Attention was concentrated on clinical trials and medical research on the treatment of depression. Original research articles, peer-reviewed publications, subject-matter expert studies, and clinical trials were reviewed for relevance and credibility. Additional information was gathered from databases such as PubMed, Google Scholar, and the National Library of Medicine to discuss the neurobiology of MDMA abuse in depth

Article Analysis

Article 1

Sessa, B. (2017). MDMA and treatment of PTSD. Neuroscience Letters, 649, 176–180. https://doi.org/10.1016/j.neulet.2016.07.004

The research methods used in this article are literature reviews and case studies, with a specific focus on the application of MDMA as adjunctive therapy in PTSD. The author presents findings and experiences based on clinical environments, citing phase one neurophysiological studies and phase two clinical trials. Additional research is required to validate these findings because of sample size limitations. The article highlights supervised and controlled application of MDMA in clinics, underscoring distinction from ecstasy use and reaction to neurotoxicity. 

Article 2

Parrott, A. C. (2013). Human psychobiology of MDMA or “Ecstasy”: An overview of 25 years of empirical research. Human Psychopharmacology: Clinical and Experimental, 28(4), 289–307. https://doi.org/10.1002/hup.2318

This paper makes use of reviews of literature and consideration of the evidence available in examining MDMA-drug interactions (MDMA-DIs). The author considers experimental data and documented clinical cases, as well as expert judgment and clinical guideline recommendation based on available evidence. The study tries to comprehend the interaction of MDMA with other drugs and how they may be toxicologically challenging.

Article 3

Costa, G., & Gołembiowska, K. (2022). Neurotoxicity of MDMA: Main effects and mechanisms. Experimental Neurology, 347(1), 113894. https://doi.org/10.1016/j.expneurol.2021.113894

This review article outlines the latest results of the central actions of MDMA and the neurotoxicity mechanisms of the drug. The authors describe the therapeutic and detrimental effects of MDMA based on dosage, frequency, and duration of intake. Mechanisms underlying neurotoxicity are further described, such as interaction with dopamine and serotonin transporters, oxidative stress, excitotoxicity, and neuroinflammation. The review aims to assist in the creation of preventive and therapeutic interventions to counteract the adverse health consequences of MDMA.

Article 4

R., Shokry, I. M., & Callanan, J. J. (2017). Environment influencing serotonin syndrome induced by ecstasy abuse. Annals of Forensic Research and Analysis, 4(1), 1039. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931730/

This article critically analyzes research on the influence of non-drug variables on MDMA-induced serotonin syndrome. The authors analyze data present to describe the influence of ambient conditions on serotonergic extrasynaptic receptor responsivity and the severity of serotonin syndrome. The study identifies variables apart from the drug that influence the severity of the syndrome.

Article 5

Montgomery, C., & Roberts, C. A. (2022). Neurological and cognitive changes induced by MDMA in humans. Experimental Neurology, 347(1), 113888. https://doi.org/10.1016/j.expneurol.2021.113888

This study defines the neurological and cognitive effects of MDMA, taking into account human-based data and describing likely cognitive alterations in relation to chronic MDMA exposure. The study points to challenges encountered in establishing serotonergic neurotoxicity in humans due to confounding factors and reliance on self-reports. Structural and functional alterations in the brain as a result of ecstasy use are noted, while acknowledging that more research is needed to elucidate its long-term effects.

Conclusion

The challenged articles supply critical information about diverse aspects of MDMA use and its implications. The research points to the potential therapeutic benefits of MDMA in managed conditions, while concurrently pointing to the harmful aspects, such as combinations with other drugs and neurotoxicity. Further research takes highest priority in addressing the risks and benefits of MDMA use and in establishing necessary preventive and therapeutic measures to minimize its unfavorable health outcomes.